1. Home
  2. EMA vs NBIX Comparison

EMA vs NBIX Comparison

Compare EMA & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMA
  • NBIX
  • Stock Information
  • Founded
  • EMA 1998
  • NBIX 1992
  • Country
  • EMA Canada
  • NBIX United States
  • Employees
  • EMA N/A
  • NBIX N/A
  • Industry
  • EMA Electric Utilities: Central
  • NBIX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EMA Utilities
  • NBIX Health Care
  • Exchange
  • EMA Nasdaq
  • NBIX Nasdaq
  • Market Cap
  • EMA 14.3B
  • NBIX 14.4B
  • IPO Year
  • EMA N/A
  • NBIX 1996
  • Fundamental
  • Price
  • EMA $47.86
  • NBIX $137.03
  • Analyst Decision
  • EMA Hold
  • NBIX Strong Buy
  • Analyst Count
  • EMA 1
  • NBIX 17
  • Target Price
  • EMA $68.00
  • NBIX $163.71
  • AVG Volume (30 Days)
  • EMA 146.5K
  • NBIX 884.9K
  • Earning Date
  • EMA 01-01-0001
  • NBIX 10-29-2025
  • Dividend Yield
  • EMA 4.32%
  • NBIX N/A
  • EPS Growth
  • EMA 15.04
  • NBIX 2.97
  • EPS
  • EMA 2.18
  • NBIX 3.39
  • Revenue
  • EMA $6,033,610,485.00
  • NBIX $2,509,900,000.00
  • Revenue This Year
  • EMA $21.63
  • NBIX $20.75
  • Revenue Next Year
  • EMA N/A
  • NBIX $14.73
  • P/E Ratio
  • EMA $22.32
  • NBIX $40.41
  • Revenue Growth
  • EMA 12.01
  • NBIX 18.42
  • 52 Week Low
  • EMA $43.90
  • NBIX $84.23
  • 52 Week High
  • EMA $49.01
  • NBIX $154.61
  • Technical
  • Relative Strength Index (RSI)
  • EMA 60.65
  • NBIX 42.80
  • Support Level
  • EMA $47.40
  • NBIX $135.59
  • Resistance Level
  • EMA $48.35
  • NBIX $148.00
  • Average True Range (ATR)
  • EMA 0.53
  • NBIX 2.83
  • MACD
  • EMA 0.17
  • NBIX -1.27
  • Stochastic Oscillator
  • EMA 80.23
  • NBIX 11.60

About EMA Emera Incorporated Common Shares

Emera is a geographically diverse energy and services company investing in electricity generation, transmission, and distribution as well as gas transmission and utility energy services. Emera has operations throughout North America and the Caribbean countries.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

Share on Social Networks: